U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07413744) titled 'The Gut - PRO Study' on Jan. 07.
Brief Summary: The purpose of this study is to assess the safety and feasibility of an oral probiotic supplement (PS) intervention in individuals with dementia or mild-cognitive impairment (MCI) due to Alzheimer's disease or at risk of dementia due to Alzheimer's disease (AD). 40 participants will be enrolled and can expect to be on study for up to 1 year.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Alzheimer Disease
Intervention:
DRUG: Probiotic
A single dose of oral PS will be administered once daily for 6 months
OTHER: Placebo
A placebo will be given once daily for...